CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 6,500 shares at $279.90 ($1,819,350)
- 4 Planned sale CEVP, Disc & Safety Assessment sold 3,714 shares at $279.66 ($1,038,657)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Gift EVP, Corp Strategy & Develop gave 257 shares (gift)
- 4 Planned sale Director sold 28,733 shares at $275.00 ($7,901,575)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, Finance and CAO sold 6,645 shares at an average $260.38 ($1,730,250)
- 4 Open-market sale EVP & Chief People Officer sold 4,179 shares at $259.16 ($1,083,030)
- 144 Insider Sale of Securities
- 4 Planned sale CEVP, Disc & Safety Assessment sold 5,046 shares at $263.00 ($1,327,098)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 75,000 shares at $225.00 ($16,875,000)
Page 2 of 123 · 2,446 filings